{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:38:52Z","timestamp":1774057132215,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011458","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T21:06:59Z","timestamp":1278536819000},"page":"e11458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of CCR2-CCR5 Haplotypes and CCL3L1 Copy Number with Kawasaki Disease, Coronary Artery Lesions, and IVIG Responses in Japanese Children"],"prefix":"10.1371","volume":"5","author":[{"given":"Manju","family":"Mamtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Onouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome.","volume":"364","author":"JC Burns","year":"2004","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"b1514","DOI":"10.1136\/bmj.b1514","article-title":"Kawasaki disease.","volume":"338","author":"A Harnden","year":"2009","journal-title":"Bmj"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCULATIONAHA.107.690875","article-title":"Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.","volume":"116","author":"BW McCrindle","year":"2007","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group.","volume":"17","author":"JC Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2008.23.4.718","article-title":"Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease.","volume":"23","author":"S Cha","year":"2008","journal-title":"J Korean Med Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"149","author":"K Egami","year":"2006","journal-title":"J Pediatr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1067\/mpd.2000.104815","article-title":"Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.","volume":"137","author":"M Fukunishi","year":"2000","journal-title":"J Pediatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.","volume":"113","author":"T Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"ref9","first-page":"780","article-title":"Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.","volume":"47","author":"R Sittiwangkul","year":"2006","journal-title":"Singapore Med J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease.","volume":"153","author":"AH Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/adc.2003.032748","article-title":"Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.","volume":"89","author":"M Miura","year":"2004","journal-title":"Arch Dis Child"},{"key":"ref12","first-page":"51","article-title":"Recent developments and controversies in Kawasaki disease.","volume":"56","author":"JA Guzman-Cottrill","year":"2004","journal-title":"Minerva Pediatr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOP.0b013e328012720f","article-title":"New developments in the search for the etiologic agent of Kawasaki disease.","volume":"19","author":"AH Rowley","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2249.2006.03266.x","article-title":"The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease.","volume":"147","author":"M Biezeveld","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1086\/430953","article-title":"Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.","volume":"192","author":"JC Burns","year":"2005","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.gene.6364225","article-title":"Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.","volume":"6","author":"JC Burns","year":"2005","journal-title":"Genes Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1542\/peds.2008-0646","article-title":"Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae.","volume":"122","author":"YF Cheung","year":"2008","journal-title":"Pediatrics"},{"key":"ref18","first-page":"1408","article-title":"Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan.","volume":"35","author":"KC Hsueh","year":"2008","journal-title":"J Rheumatol"},{"key":"ref19","article-title":"The CCR5 (-2135C\/T) Polymorphism may be Associated with the Development of Kawasaki Disease in Korean Children.","author":"WK Jhang","year":"2008","journal-title":"J Clin Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A","article-title":"Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease.","volume":"44","author":"T Jibiki","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1203\/01.PDR.0000145280.26284.B9","article-title":"Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.","volume":"56","author":"H Kariyazono","year":"2004","journal-title":"Pediatr Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.","volume":"40","author":"Y Onouchi","year":"2008","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/S0022-3476(03)00330-5","article-title":"A polymorphism in the promoter of the CD14 gene (CD14\/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.","volume":"143","author":"S Nishimura","year":"2003","journal-title":"J Pediatr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3346\/jkms.2005.20.4.607","article-title":"Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.","volume":"20","author":"JA Park","year":"2005","journal-title":"J Korean Med Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2146\/ajhp050283","article-title":"Clinical and investigational considerations for the use of IGIV therapy.","volume":"62","author":"M Ballow","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.2007.03457.x","article-title":"Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.","volume":"150","author":"WB Breunis","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1101160","article-title":"The influence of CCL3L1 gene-containing segmental duplications on HIV-1\/AIDS susceptibility.","volume":"307","author":"E Gonzalez","year":"2005","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm0798-786","article-title":"Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.","volume":"4","author":"S Mummidi","year":"1998","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D","article-title":"Gene copy number regulates the production of the human chemokine CCL3-L1.","volume":"32","author":"JR Townson","year":"2002","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.1072047","article-title":"Recent segmental duplications in the human genome.","volume":"297","author":"JA Bailey","year":"2002","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05329","article-title":"Global variation in copy number in the human genome.","volume":"444","author":"R Redon","year":"2006","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.091056898","article-title":"Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.","volume":"98","author":"E Gonzalez","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).","volume":"47","author":"M Ayusawa","year":"2005","journal-title":"Pediatr Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(05)81894-3","article-title":"Outcome of coronary artery aneurysms after Kawasaki disease.","volume":"121","author":"T Akagi","year":"1992","journal-title":"J Pediatr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"18946","DOI":"10.1074\/jbc.M000169200","article-title":"Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus.","volume":"275","author":"S Mummidi","year":"2000","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/bioinformatics\/bti282","article-title":"PowerMarker: an integrated analysis environment for genetic marker analysis.","volume":"21","author":"K Liu","year":"2005","journal-title":"Bioinformatics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/ard.2007.078048","article-title":"CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.","volume":"67","author":"M Mamtani","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/gene.2009.71","article-title":"Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases.","volume":"11","author":"M Mamtani","year":"2010","journal-title":"Genes Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1.","volume":"13","author":"P Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2005.03.037","article-title":"A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.","volume":"147","author":"T Minami","year":"2005","journal-title":"J Pediatr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2249.2000.01395.x","article-title":"Expression of IL-8 in Kawasaki disease.","volume":"122","author":"T Asano","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-3083.2000.00650.x","article-title":"Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.","volume":"51","author":"T Asano","year":"2000","journal-title":"Scand J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jlb.65.5.566","article-title":"Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.","volume":"65","author":"M Terai","year":"1999","journal-title":"J Leukoc Biol"},{"key":"ref44","first-page":"1179","article-title":"Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease.","volume":"24","author":"M Wong","year":"1997","journal-title":"J Rheumatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease.","volume":"47","author":"K Takahashi","year":"2005","journal-title":"Pediatr Int"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk.","volume":"28","author":"P Aukrust","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00431-006-0251-8","article-title":"Predictive risk factors for coronary artery abnormalities in Kawasaki disease.","volume":"166","author":"T Kim","year":"2007","journal-title":"Eur J Pediatr"},{"key":"ref48","first-page":"332","article-title":"[Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].","volume":"66","author":"T Kobayashi","year":"2008","journal-title":"Nippon Rinsho"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.","volume":"166","author":"T Sano","year":"2007","journal-title":"Eur J Pediatr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2006.11.010","article-title":"FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.","volume":"26","author":"KH Park-Min","year":"2007","journal-title":"Immunity"},{"key":"ref51","first-page":"61","article-title":"The effector T helper cell triade.","volume":"102","author":"P Fietta","year":"2009","journal-title":"Riv Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","article-title":"How interferon-gamma keeps autoimmune diseases in check.","volume":"29","author":"H Kelchtermans","year":"2008","journal-title":"Trends Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/34814","article-title":"CCR5 is characteristic of Th1 lymphocytes.","volume":"391","author":"P Loetscher","year":"1998","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajhg.2008.08.019","article-title":"Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies.","volume":"83","author":"Y Yamaguchi-Kabata","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2003.09.003","article-title":"C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis.","volume":"145","author":"R Miyagishi","year":"2003","journal-title":"J Neuroimmunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1164\/ajrccm.159.6.9810020","article-title":"The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population.","volume":"159","author":"N Hizawa","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref57","article-title":"Polymorphisms of coreceptor-related genes associated with HIV-1 disease progression and infection in Japanese hemophiliacs;","author":"XW Deng"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","article-title":"Coronary artery dimensions may be misclassified as normal in Kawasaki disease.","volume":"133","author":"A de Zorzi","year":"1998","journal-title":"J Pediatr"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:06:42Z","timestamp":1685664402000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011458"}},"subtitle":[],"editor":[{"given":"Anita","family":"Brandstaetter","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}